Conviction
$ Value
$478K
Shares
15,000
Price
$32
Filed
May 2
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Hayden Michael R
Title
—
CIK
0001352908
Roles
Transaction Details
Transaction Date
2025-05-01
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
50,219
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchase in multiple transactions at prices ranging from $31.50 to $32.09 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) on this Form 4. | These securities are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2.
Filing Info
Hayden Michael R's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-10-30 | ETNB | U | — |
| 2025-10-30 | ETNB | U | — |
| 2025-10-30 | ETNB | U | — |
| 2025-10-30 | ETNB | D | $0 |
| 2025-10-30 | ETNB | D | $0 |
| 2025-10-30 | ETNB | D | $0 |
| 2025-10-30 | ETNB | D | $0 |
| 2025-10-30 | ETNB | D | $0 |
| 2025-10-30 | ETNB | D | $0 |
| 2025-10-30 | ETNB | D | $0 |
Other Insiders at IONS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| PARSHALL B LYNNE | — | $381K | 2026-04-15 |
|
BENNETT C FRANK
EVP, Chief Scientific Officer
|
— | $7.5M | 2026-02-02 |
|
HOUGEN ELIZABETH L
EVP, Finance & CFO
|
— | $582K | 2026-01-30 |
| KLEIN JOSEPH III | — | $1.7M | 2026-04-01 |
|
Monia Brett P
Chief Executive Officer
|
— | $5.2M | 2026-01-30 |
|
O'NEIL PATRICK R.
EVP CLO & General Counsel
|
— | $516K | 2026-01-30 |
|
Swayze Eric
EVP Research
|
— | $512K | 2026-01-30 |
|
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
|
— | $368K | 2026-04-16 |
|
Baroldi Joseph
EVP, Chief Business Officer
|
— | $858K | 2026-04-16 |
|
Schneider Eugene
EVP, Chf Clinical Develop Ofcr
|
— | $516K | 2026-01-30 |
|
Birchler Brian
EVP, Corp and Development Ops
|
— | $586K | 2026-04-16 |
|
Devers Shannon L.
EVP, Chief Human Resources Ofc
|
— | $459K | 2026-04-02 |